The Use of Neuroimaging to Assess Associations Among Diet, Nutrients, Metabolic Syndrome, and Alzheimer's Disease.

In the last decade, specific dietary patterns, mainly characterized by high consumption of vegetables and fruits, have been proven beneficial for the prevention of both metabolic syndrome (MetS)-related dysfunctions and neurodegenerative disorders, such as Alzheimer's disease (AD). Nowadays, neuroimaging readouts can be used to diagnose AD, investigate MetS effects on brain functionality and anatomy, and assess the effects of dietary supplementations and nutritional patterns in relation to neurodegeneration and AD-related features. Here we review scientific literature describing the use of the most recent neuroimaging techniques to detect AD- and MetS-related brain features, and also to investigate associations between consolidated dietary patterns or nutritional interventions and AD, specifically focusing on observational and intervention studies in humans.

[1]  A. Kowaltowski,et al.  Dietary restriction in cerebral bioenergetics and redox state☆ , 2014, Redox biology.

[2]  Xue Hua,et al.  Homocysteine effects on brain volumes mapped in 732 elderly individuals , 2011, Neuroreport.

[3]  I. Bauer,et al.  Acute Effects of Different Multivitamin Mineral Preparations with and without Guaraná on Mood, Cognitive Performance and Functional Brain Activation , 2013, Nutrients.

[4]  Y. Dinçer,et al.  Alzheimer's disease and epigenetic diet , 2014, Neurochemistry International.

[5]  M. Kamal,et al.  Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies. , 2014, CNS & neurological disorders drug targets.

[6]  Yuan Feng,et al.  Aberrant Brain Functional Connectivity Related to Insulin Resistance in Type 2 Diabetes: A Resting-State fMRI Study , 2014, Diabetes Care.

[7]  T. Anekonda Resveratrol—A boon for treating Alzheimer's disease? , 2006, Brain Research Reviews.

[8]  M. D. de Leon,et al.  Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer’s: A Multi-Modality Brain Imaging Study , 2014, Advances in molecular imaging.

[9]  C. Mun,et al.  Apolipoprotein E genotype modulates effects of vitamin B12 and homocysteine on grey matter volume in Alzheimer's disease , 2016, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

[10]  Lucia Kerti,et al.  Effects of Resveratrol on Memory Performance, Hippocampal Functional Connectivity, and Glucose Metabolism in Healthy Older Adults , 2014, The Journal of Neuroscience.

[11]  O. Ukoumunne,et al.  ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). , 2014, The Cochrane database of systematic reviews.

[12]  J. Blass Mediterranean Diet and Mild Cognitive Impairment , 2009 .

[13]  W. Klunk,et al.  Development of positron emission tomography β-amyloid plaque imaging agents. , 2012, Seminars in nuclear medicine.

[14]  H. Braak,et al.  Where, when, and in what form does sporadic Alzheimer's disease begin? , 2012, Current opinion in neurology.

[15]  A. Martí,et al.  A 3 years follow-up of a Mediterranean diet rich in virgin olive oil is associated with high plasma antioxidant capacity and reduced body weight gain , 2009, European Journal of Clinical Nutrition.

[16]  M. Sabbagh,et al.  Are certain lifestyle habits associated with lower Alzheimer's disease risk? , 2010, Journal of Alzheimer's disease : JAD.

[17]  Robert A. Gross,et al.  Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study , 2012 .

[18]  S. Rapoport Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[19]  Sterling C. Johnson,et al.  Calorie Restriction Reduces the Influence of Glucoregulatory Dysfunction on Regional Brain Volume in Aged Rhesus Monkeys , 2012, Diabetes.

[20]  P. Thompson,et al.  Regular fish consumption and age-related brain gray matter loss. , 2014, American journal of preventive medicine.

[21]  D. K. Johnson,et al.  Insulin resistance and gray matter volume in neurodegenerative disease , 2014, Neuroscience.

[22]  A. McKinney,et al.  Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease , 2010 .

[23]  L. Tan,et al.  Resveratrol as a Therapeutic Agent for Alzheimer's Disease , 2014, BioMed research international.

[24]  Ronald C Petersen,et al.  Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. , 2014, Journal of Alzheimer's disease : JAD.

[25]  P. Kamphuis,et al.  Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. , 2013, Journal of Alzheimer's disease : JAD.

[26]  Cécile Proust-Lima,et al.  Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe , 2012, Neurology.

[27]  Karen F Berman,et al.  The neurobiology of Alzheimer disease defined by neuroimaging. , 2012, Current opinion in neurology.

[28]  Carole Dufouil,et al.  Plasma lipids and cerebral small vessel disease , 2014, Neurology.

[29]  G. Kemmler,et al.  Conversion from mild cognitive impairment to dementia: Influence of folic acid and vitamin B12 use in the vita cohort , 2012, The journal of nutrition, health & aging.

[30]  Cornelis J. Stam,et al.  The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer’s Disease: A Randomised Controlled Study , 2014, PloS one.

[31]  L. Donini,et al.  Nutritional status determinants and cognition in the elderly. , 2007, Archives of gerontology and geriatrics.

[32]  Yaakov Stern,et al.  Physical activity, diet, and risk of Alzheimer disease. , 2009, JAMA.

[33]  Abderrahim Oulhaj,et al.  Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial , 2010, PloS one.

[34]  S. Ferreira,et al.  Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease , 2014, Alzheimer's & Dementia.

[35]  A. Lerner Amyloid imaging , 2013, Neurology.

[36]  A. Kontush,et al.  Vitamin E in Neurodegenerative Disorders: Alzheimer's Disease , 2004, Annals of the New York Academy of Sciences.

[37]  Ashley R. Morgan,et al.  Acute effect of a high nitrate diet on brain perfusion in older adults. , 2011, Nitric oxide : biology and chemistry.

[38]  K. Shpanskaya,et al.  Impact of 18F-florbetapir PET imaging of β-amyloid neuritic plaque density on clinical decision-making , 2014, Neurocase.

[39]  S. M. de la Monte,et al.  Brain metabolic dysfunction at the core of Alzheimer's disease. , 2014, Biochemical pharmacology.

[40]  S. Rapoport,et al.  Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans , 2012, Brain Research Bulletin.

[41]  Shankar Vallabhajosula,et al.  Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study , 2014, BMJ Open.

[42]  Cornelis J Stam,et al.  Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. , 2012, Journal of Alzheimer's disease : JAD.

[43]  R. Lamuela-Raventós,et al.  Mediterranean diet and oxidation: nuts and olive oil as important sources of fat and antioxidants. , 2011, Current topics in medicinal chemistry.

[44]  U. Broedl,et al.  Adipokines and Insulin Resistance , 2008, Molecular medicine.

[45]  P. Wolf,et al.  The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort. , 2011, The American journal of clinical nutrition.

[46]  J. Grimley Evans,et al.  Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. , 2008, The Cochrane database of systematic reviews.

[47]  C. Murphy The Chemical Senses and Nutrition in Older Adults , 2008, Journal of nutrition for the elderly.

[48]  Kerry Jones,et al.  Vitamin D and cognitive function , 2012, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[49]  Lars Bäckman,et al.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.

[50]  G. Bigford,et al.  Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders. , 2014, Advances in nutrition.

[51]  C. Chen,et al.  Impacts of hyper-homocysteinemia and white matter hyper-intensity in Alzheimer's disease patients with normal creatinine: an MRI-based study with longitudinal follow-up. , 2010, Current Alzheimer research.

[52]  The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease , 2013, Alzheimer's Research & Therapy.

[53]  Yaakov Stern,et al.  Mediterranean diet, Alzheimer disease, and vascular mediation. , 2006, Archives of neurology.

[54]  P. Scheltens,et al.  Efficacy of a medical food on cognition in Alzheimer’s Disease: Results from secondary analyses of a randomized, controlled trial , 2011, The journal of nutrition, health & aging.

[55]  C. Duyckaerts,et al.  Alzheimer disease models and human neuropathology: similarities and differences , 2007, Acta Neuropathologica.

[56]  S. Arlt,et al.  Effect of One-Year Vitamin C- and E-Supplementation on Cerebrospinal Fluid Oxidation Parameters and Clinical Course in Alzheimer’s Disease , 2012, Neurochemical Research.

[57]  J. Jhamandas,et al.  Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease. , 2014, Current Alzheimer research.

[58]  Allan Reiss,et al.  Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease , 2013, Neurobiology of Aging.

[59]  Sterling C. Johnson,et al.  Low cerebral blood flow is associated with lower memory function in metabolic syndrome , 2012, Obesity.

[60]  A. Brickman,et al.  Mediterranean diet and magnetic resonance imaging–assessed cerebrovascular disease , 2011, Annals of neurology.

[61]  Thomas E. Nichols,et al.  Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment , 2013, Proceedings of the National Academy of Sciences.

[62]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[63]  J. Kaye,et al.  Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging , 2011, Neurology.

[64]  Sterling C. Johnson,et al.  Calorie restriction reduces psychological stress reactivity and its association with brain volume and microstructure in aged rhesus monkeys , 2012, Psychoneuroendocrinology.

[65]  P. Scheltens,et al.  Utility of imaging for nutritional intervention studies in Alzheimer's disease. , 2011, European journal of pharmacology.

[66]  A. Hofman,et al.  Total antioxidant capacity of the diet and major neurologic outcomes in older adults , 2013, Neurology.

[67]  Liang Shen,et al.  Associations between Homocysteine, Folic Acid, Vitamin B12 and Alzheimer's Disease: Insights from Meta-Analyses. , 2015, Journal of Alzheimer's disease : JAD.

[68]  M. Martínez-González,et al.  Mediterranean Diet Inversely Associated With the Incidence of Metabolic Syndrome , 2007, Diabetes Care.

[69]  J. Silverman,et al.  Cardiovascular risk factors for Alzheimer's disease. , 2007, The American journal of geriatric cardiology.

[70]  Tyler E. Benedum,et al.  Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent. , 2011, Seminars in nuclear medicine.

[71]  K. Bürger,et al.  Taste in mild cognitive impairment and Alzheimer’s disease , 2010, Journal of Neurology.

[72]  P. Amiano,et al.  Diet, cognition, and Alzheimer’s disease: food for thought , 2014, European Journal of Nutrition.

[73]  F. D. Felice Alzheimer’s disease and insulin resistance: translating basic science into clinical applications , 2013 .

[74]  Chibuike C. Udenigwe,et al.  Aroma and Taste Perceptions With Alzheimer Disease and Stroke , 2013, Critical reviews in food science and nutrition.

[75]  R. Maccioni,et al.  Nutraceuticals: a novel concept in prevention and treatment of Alzheimer's disease and related disorders. , 2014, Journal of Alzheimer's disease : JAD.

[76]  Shantanu H. Joshi,et al.  Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative , 2015, Neurobiology of Aging.

[77]  M. Battino,et al.  Role of plant-based diets in the prevention and regression of metabolic syndrome and neurodegenerative diseases , 2014 .

[78]  Eric D. Vidoni,et al.  Impaired glycemia increases disease progression in mild cognitive impairment , 2014, Neurobiology of Aging.

[79]  K. Yurko-Mauro Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline. , 2010, Current Alzheimer research.

[80]  A. B. Scholey,et al.  Improved cognitive performance and mental fatigue following a multi-vitamin and mineral supplement with added guaraná (Paullinia cupana) , 2008, Appetite.

[81]  M. Iyo,et al.  Positron Emission Tomographic Measurement of Brain Acetylcholinesterase Activity Using N-[11C]methylpiperidin-4-yl Acetate Without Arterial Blood Sampling: Methodology of Shape Analysis and its Diagnostic Power for Alzheimer's Disease , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[82]  B. Winblad,et al.  Vitamin D in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumes. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[83]  I. Deary,et al.  Plasma vitamin C, cholesterol and homocysteine are associated with grey matter volume determined by MRI in non-demented old people , 2003, Neuroscience Letters.

[84]  Yemisi Takwoingi,et al.  (11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). , 2014, The Cochrane database of systematic reviews.

[85]  Olivier Salvado,et al.  Addressing population aging and Alzheimer's disease through the Australian Imaging Biomarkers and Lifestyle study: Collaboration with the Alzheimer's Disease Neuroimaging Initiative , 2010, Alzheimer's & Dementia.

[86]  D. Ingram,et al.  Nutrition, Brain Aging, and Neurodegeneration , 2009, The Journal of Neuroscience.

[87]  N. Bryan,et al.  Food sources of nitrates and nitrites: the physiologic context for potential health benefits. , 2009, The American journal of clinical nutrition.

[88]  K. Meguro,et al.  Disorders of “taste cognition” are associated with insular involvement in patients with Alzheimer's disease and vascular dementia: “Memory of food is impaired in dementia and responsible for poor diet” , 2014, International Psychogeriatrics.

[89]  W H Tsui,et al.  Mediterranean Diet and Magnetic Resonance Imaging-Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Disease. , 2014, The journal of prevention of Alzheimer's disease.

[90]  H. Koek,et al.  The influence of vascular risk factors on cognitive decline in patients with dementia: a systematic review. , 2013, Maturitas.

[91]  M. Romano,et al.  Florbetapir F 18 for brain imaging of β-amyloid plaques. , 2013, Drugs of today.

[92]  Michael Weiner,et al.  Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. , 2010, JAMA.

[93]  N. Scarmeas,et al.  Diet and Neuroimaging Markers of Cerebrovascular Disease , 2013, Current Nutrition Reports.

[94]  Zhichun Chen,et al.  Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies , 2013, Progress in Neurobiology.

[95]  Helgi B. Schiöth,et al.  Mediterranean diet habits in older individuals: Associations with cognitive functioning and brain volumes , 2013, Experimental Gerontology.

[96]  Maria C. Carrillo,et al.  Maximizing the Alzheimer's Disease Neuroimaging Initiative II , 2009, Alzheimer's & Dementia.

[97]  C. Annweiler,et al.  Nutrient Biomarker Patterns, Cognitive Function, and Mri Measures of Brain Aging , 2012, Neurology.

[98]  Yi Li,et al.  FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease , 2014, Advances in molecular imaging.

[99]  G. Wenk,et al.  Neuropathologic changes in Alzheimer's disease. , 2003, The Journal of clinical psychiatry.

[100]  J. Hardy,et al.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.

[101]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[102]  Sterling C. Johnson,et al.  Insulin resistance predicts brain amyloid deposition in late middle-aged adults , 2015, Alzheimer's & Dementia.

[103]  N. Herrmann,et al.  A functional neuroimaging study of appetite loss in Alzheimer’s disease , 2008, Journal of the Neurological Sciences.